EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The role of e3 ubiquitin ligases and deubiquitinating enzymes in hepatocellular carcinoma

Lei Wang, Hongyan Zhang, Yue Hu, Xingqiang Li, Jing Liu, Ying Liang

Cell Biology and Toxicology · 2026

DOI: 10.1007/s10565-026-10192-1 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Biology and Toxicology, 2026. Verfasst von Lei Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, the First Hospital of China Medical University, Shenyang, Liaoning, PR China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Ubiquitin-Protein Ligases, Deubiquitinating Enzymes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ubiquitination, a key post-translational modification, is responsible for regulating protein stability, activity, subcellular localization, and interactions via the ubiquitin-proteasome system (UPS). The UPS plays a role in non-lysosomal protein degradation, involved in the coordinated action of ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s), and ubiquitin ligases (E3s). The review elaborates on the functions of key E3 ligases of MDM2, β-TrCP, and SCF complexes, which modulate cell cycle progression, apoptosis, metabolic reprogramming, and drug resistance in hepatocellular carcinoma (HCC). For instance, MDM2 promotes HCC development by degrading the tumor suppressor p53, while β-TrCP influences the Wnt/β-catenin signaling axis by changing β-catenin levels. Deubiquitinating enzymes (DUBs), including the USP family and CYLD, also play significant roles in HCC by stabilizing or destabilizing critical proteins involved in oncogenesis. The clinical potential of ubiquitination-related molecules as biomarkers for predicting HCC prognosis and as therapeutic targets is also discussed. This review comprehensively examines the role of ubiquitination modification in HCC and its clinical relevance. Future research directions include the exploration of novel ubiquitination modifications, their interactions with other post-translational modifications, and the development of precision medicine strategies based on multi-omics technologies to improve HCC treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsUbiquitin-Protein LigasesDeubiquitinating EnzymesHumansUbiquitinationAnimals

Stichwörter der Autor:innen

Deubiquitinating enzymesE3 ubiquitin ligasesHepatocellular carcinomaUbiquitination

Substanzen

Ubiquitin-Protein LigasesDeubiquitinating Enzymes

Autor:innen und Institutionen

  • Department of Hematology, the First Hospital of China Medical University, Shenyang, Liaoning, PR China.
  • Department of Neurology, the Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, PR China.
  • Department of Otolaryngology, the First Hospital of China Medical University, Shenyang, Liaoning, PR China.
  • Department of Neurology, the Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, PR China. lixingqiangydsy@163.com.
  • Department of Obstetrics, the First Hospital of China Medical University, Shenyang, China. liujing9936@163.com.
  • Department of Hematology, the First Hospital of China Medical University, Shenyang, Liaoning, PR China. liangying002950@163.com.

Zitieren

APA

Wang, L., Zhang, H., Hu, Y., Li, X., Liu, J., & Liang, Y. (2026). The role of e3 ubiquitin ligases and deubiquitinating enzymes in hepatocellular carcinoma. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-026-10192-1

Vancouver

Wang L, Zhang H, Hu Y, Li X, Liu J, Liang Y. The role of e3 ubiquitin ligases and deubiquitinating enzymes in hepatocellular carcinoma. Cell Biology and Toxicology. 2026. doi:10.1007/s10565-026-10192-1

BibTeX
@article{Wang2026,
  author = {Wang, Lei and Zhang, Hongyan and Hu, Yue and Li, Xingqiang and Liu, Jing and Liang, Ying},
  title = {The role of e3 ubiquitin ligases and deubiquitinating enzymes in hepatocellular carcinoma},
  journal = {Cell Biology and Toxicology},
  year = {2026},
  doi = {10.1007/s10565-026-10192-1}
}
Kostenlos starten →